Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GlucoTrack, Inc. (GCTK : NSDQ)

• Company Description    GlucoTrack Inc. is an innovator of GlucoTrack(R), a non-invasive device and digital health platform for measuring glucose levels in people with Type 2 diabetes and prediabetes. GlucoTrack Inc., formerly known as Integrity Applications Inc., is based in Rutherford, NJ. Number of Employees: 15

• Price / Volume Information    Yesterday's Closing Price: $0.67 Daily Weekly Monthly 20 Day Moving Average: 10,967,022 shares Shares Outstanding: 1.94 (millions) Market Capitalization: $1.30 (millions) Beta: 0.78 52 Week High: $14.14 52 Week Low: $0.58 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -9.72% -15.25% 12 Week -58.65% -62.17% Year To Date -82.69% -84.20%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 301 RT 17 NORTH SUITE 800 - RUTHERFORD,NJ 07070 USA ph: 201-842-7715 fax: - investors@glucotrack.com http://www.glucotrack.com

• General Corporate Information    Officers Paul Goode - Chief Executive Officer and Director Peter Wulff - Chief Financial Officer Erin Carter - Director Luis Malave - Director Andrew Balo - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 45824Q804 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 1.94 Most Recent Split Date: 6.00 (0.02:1) Beta: 0.78 Market Capitalization: $1.30 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.24 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 86.98% vs. Previous Quarter: -134.51% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -406.67 12/31/25 - -324.84 09/30/25 - -2,311.96 ROA 03/31/26 - -192.37 12/31/25 - -178.16 09/30/25 - -264.11 Current Ratio 03/31/26 - - 12/31/25 - 1.61 09/30/25 - 1.53 Quick Ratio 03/31/26 - - 12/31/25 - 1.61 09/30/25 - 1.53 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - 2.80 09/30/25 - 3.02 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - 0.08 09/30/25 - 0.08 Debt-to-Capital 03/31/26 - - 12/31/25 - 7.55 09/30/25 - 7.62

Powered by Zacks Investment Research ©